Answers are grounded in this paper and cite their sources.
This study investigates a low-carbon mortar in which 60% of the Portland composite cement (PCC) was replaced by fly ash (40%), limestone powder (15%), and metakaolin (5%), reinforced with alkali-treated bamboo cellulose (CB) or cocopeat cellulose (CCP), and containing recycled brick aggregate (RA) as a 20% replacement for natural sand. First, the CB dosage was varied from 0.5% to 2% of binder mass in plain cement mortar; 1.5% gave the highest 28-day compressive strength (29.9 MPa versus 25.3 MPa for the control) and was adopted for the second stage. Compressive (7 and 28 days) and flexural (28 days) strengths were measured, and hydration and microstructure were examined by X-ray diffraction (XRD) and scanning electron microscopy with energy-dispersive spectroscopy (SEM-EDS). The pozzolanic binder and the cellulose reduced the 7-day compressive strength by up to 32%. XRD indicated that both celluloses retarded early clinker hydration but promoted carboaluminate formation by 28 days, when the fiber mixtures reached 17.2–17.4 MPa, versus 16.6 MPa for the plain pozzolan mortar and 20.0 MPa for the control. The fiber mixtures containing RA reached 20.0–20.1 MPa. Bamboo cellulose gave the highest flexural strength, 5.61 MPa, 31% above the control and 14% above the plain pozzolan mortar, and SEM showed intact bamboo fibers bridging pores, whereas cocopeat cellulose left it practically unchanged (4.98 versus 4.90 MPa). The load–displacement curves showed that bamboo cellulose raised both the peak load and the displacement at failure of the pozzolan mortar, consistent with microcrack bridging, although no mixture showed a post-peak softening branch. RA reduced the flexural strength of the bamboo and cocopeat mixtures by 33% and 28%, to 3.78 and 3.59 MPa, respectively, below that of the control. The bamboo cellulose mortar with RA therefore offers the best balance of clinker reduction, waste valorization, and strength, with flexural performance as the main limitation.
No takes yet. Share an insight, caveat, or question.
Supit et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: